Vanguard Group’s Repare Therapeutics RPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,857
| Closed | -$52.1K | – | 4321 |
|
|
2025
Q1 | $52.1K | Sell |
52,857
-1,408
| -3% | -$1.39K | ﹤0.01% | 4190 |
|
|
2024
Q4 | $71.1K | Sell |
54,265
-832
| -2% | -$1.09K | ﹤0.01% | 4188 |
|
|
2024
Q3 | $190K | Sell |
55,097
-448
| -0.8% | -$1.54K | ﹤0.01% | 4149 |
|
|
2024
Q2 | $183K | Sell |
55,545
-296
| -0.5% | -$977 | ﹤0.01% | 4177 |
|
|
2024
Q1 | $263K | Sell |
55,841
-6,818
| -11% | -$32.1K | ﹤0.01% | 4133 |
|
|
2023
Q4 | $457K | Sell |
62,659
-12,403
| -17% | -$90.5K | ﹤0.01% | 4064 |
|
|
2023
Q3 | $907K | Buy |
75,062
+500
| +0.7% | +$6.04K | ﹤0.01% | 3873 |
|
|
2023
Q2 | $789K | Sell |
74,562
-540
| -0.7% | -$5.71K | ﹤0.01% | 3971 |
|
|
2023
Q1 | $739K | Hold |
75,102
| – | – | ﹤0.01% | 3998 |
|
|
2022
Q4 | $1.1M | Buy |
75,102
+1,260
| +2% | +$18.5K | ﹤0.01% | 3879 |
|
|
2022
Q3 | $895K | Buy |
73,842
+600
| +0.8% | +$7.27K | ﹤0.01% | 4039 |
|
|
2022
Q2 | $1.02M | Buy |
73,242
+8,773
| +14% | +$123K | ﹤0.01% | 4077 |
|
|
2022
Q1 | $918K | Buy |
64,469
+360
| +0.6% | +$5.13K | ﹤0.01% | 4235 |
|
|
2021
Q4 | $1.35M | Buy |
64,109
+29,065
| +83% | +$613K | ﹤0.01% | 4172 |
|
|
2021
Q3 | $920K | Buy |
35,044
+1,270
| +4% | +$33.3K | ﹤0.01% | 4263 |
|
|
2021
Q2 | $1.05M | Sell |
33,774
-134
| -0.4% | -$4.18K | ﹤0.01% | 4140 |
|
|
2021
Q1 | $1.04M | Buy |
33,908
+2,489
| +8% | +$76.4K | ﹤0.01% | 4001 |
|
|
2020
Q4 | $1.08M | Buy |
+31,419
| New | +$1.08M | ﹤0.01% | 3809 |
|